Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 18901-18950 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT02756962
Improving Risk Assessment of AML With a Precision Genomic Strategy to Assess Mutation Clearance
PHASE2
Active, not recruiting
107 participants
Started: Jul 6, 2016 · Completed: Jul 31, 2029
1 condition
3 sponsors
3 locations
NCT02726997
Matched Paired Pharmacodynamics and Feasibility Study of Durvalumab in Combination With Chemotherapy in Frontline Ovarian Cancer (N-Dur)
PHASE1/PHASE2
Active, not recruiting
18 participants
Started: Jul 6, 2016 · Completed: Dec 31, 2025
15 conditions
2 sponsors
1 location
NCT03729687
Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer
PHASE2
Active, not recruiting
280 participants
Started: Jul 4, 2016 · Completed: Jun 30, 2025
1 condition
2 sponsors
1 location
NCT05156580
Tongzhou Cohort Study
N/A
Active, not recruiting
31,080 participants
Started: Jul 1, 2016 · Completed: Sep 1, 2026
2 conditions
4 sponsors
1 location
NCT02938299
Neoadjuvant L19IL2/L19TNF- Pivotal Study
PHASE3
Active, not recruiting
214 participants
Started: Jul 1, 2016 · Completed: Dec 31, 2028
1 condition
1 sponsor
22 locations
NCT05513651
Establishment of a Model for Predicting the Prognosis of HBV-related Decompensated Liver Cirrhosis Based on RFH-NPT
N/A
Active, not recruiting
2,000 participants
Started: Jul 1, 2016 · Completed: Dec 30, 2030
2 conditions
1 sponsor
1 location
NCT02653092
Reprometabolic Syndrome Mediates Subfertility in Obesity
NA
Active, not recruiting
84 participants
Started: Jun 30, 2016 · Completed: Dec 11, 2025
4 conditions
2 sponsors
1 location
NCT02760914
Adipose Tissue and Inflammation in Coronary Heart Disease
N/A
Active, not recruiting
50 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT02673424
Fractional FLow Reserve And IVUS for Clinical OUtcomes in Patients With InteRmediate Stenosis
NA
Active, not recruiting
1,700 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2025
1 condition
8 sponsors
5 locations
NCT02823002
Pain Perception: Lidocaine Rate/Temp/Buffer
NA
Active, not recruiting
26 participants
Started: Jun 30, 2016 · Completed: Jan 31, 2025
1 condition
1 sponsor
1 location
NCT02816697
Implementation of a System-level Tobacco Treatment Intervention
NA
Active, not recruiting
263 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2025
2 conditions
3 sponsors
2 locations
NCT02685891
Brain Maturation and Sleep
NA
Active, not recruiting
90 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02565498
Preoperative vs Postoperative IMRT for Extremity/Truncal STS
PHASE3
Active, not recruiting
210 participants
Started: Jun 30, 2016 · Completed: May 31, 2029
1 condition
2 sponsors
8 locations
NCT06316609
Prenatal Exposure to Emerging Contaminants and Children's Atopic Dermatitis
N/A
Active, not recruiting
456 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2027
1 condition
3 sponsors
1 location
NCT02813980
Neural Circulatory Control and SUDEP Risk.
N/A
Active, not recruiting
39 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2030
2 conditions
2 sponsors
1 location
NCT02742454
VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants
NA
Active, not recruiting
570 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2023
1 condition
12 sponsors
12 locations
NCT02862938
Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
PHASE2
Active, not recruiting
54 participants
Started: Jun 30, 2016 · Completed: Dec 15, 2025
1 condition
1 sponsor
1 location
NCT02795442
Daily Protein Intake Patterns on Energy Metabolism and the Motivation to Snack
NA
Active, not recruiting
26 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT02752685
Phase II Study of Pembrolizumab and Nab-paclitaxel in HER-2 Negative Metastatic Breast Cancer
PHASE2
Active, not recruiting
70 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02734771
A Study of Brentuximab Vedotin, Rituximab, and Dose Attenuated CHP in Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL)
PHASE2
Active, not recruiting
24 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT02815917
Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Jun 30, 2016 · Completed: Jun 30, 2026
3 conditions
1 sponsor
1 location
NCT02805023
BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2027
3 conditions
3 sponsors
5 locations
NCT02624596
Understanding How Ketamine Brings About Rapid Improvement in OCD
PHASE2
Active, not recruiting
120 participants
Started: Jun 30, 2016 · Completed: Jun 30, 2026
1 condition
2 sponsors
1 location
NCT02767804
eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
PHASE3
Active, not recruiting
290 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2025
1 condition
1 sponsor
72 locations
NCT02761811
Sympathetic Mapping/ Ablation of Renal Nerves Trial
NA
Active, not recruiting
220 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2026
1 condition
2 sponsors
15 locations
NCT02972580
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
N/A
Active, not recruiting
250 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2030
2 conditions
2 sponsors
1 location
NCT02825134
Comparison of TAVR With SAVR in Younger Low Surgical Risk Patients With Severe Aortic Stenosis
NA
Active, not recruiting
376 participants
Started: Jun 30, 2016 · Completed: Jun 30, 2029
5 conditions
5 sponsors
9 locations
NCT03677206
The Effect of Light Therapy on Chronic Pain
NA
Active, not recruiting
60 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03377205
Intramedullary Nailing Versus Plate Fixation of Ankle Fractures. A Prospective, Randomized Controlled Trial.
NA
Active, not recruiting
120 participants
Started: Jun 30, 2016 · Completed: Jan 31, 2026
1 condition
3 sponsors
1 location
NCT02792114
T-Cell Therapy for Advanced Breast Cancer
PHASE1
Active, not recruiting
186 participants
Started: Jun 30, 2016 · Completed: Jun 30, 2026
2 conditions
2 sponsors
7 locations
NCT02665065
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
PHASE3
Active, not recruiting
153 participants
Started: Jun 30, 2016 · Completed: Dec 31, 2026
9 conditions
1 sponsor
24 locations
NCT02743819
Pembrolizumab and Ipilimumab After Prior Immunotherapy for Melanoma
PHASE2
Active, not recruiting
70 participants
Started: Jun 28, 2016 · Completed: Jun 30, 2026
1 condition
1 sponsor
10 locations
NCT02414399
Azithromycin to Prevent Post-discharge Morbidity and Mortality in Kenyan Children
PHASE4
Active, not recruiting
1,400 participants
Started: Jun 28, 2016 · Completed: Dec 28, 2025
6 conditions
3 sponsors
1 location
NCT02629692
Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies
PHASE1/PHASE2
Active, not recruiting
122 participants
Started: Jun 27, 2016 · Completed: Aug 31, 2026
2 conditions
1 sponsor
38 locations
NCT02797470
Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant
PHASE1/PHASE2
Active, not recruiting
11 participants
Started: Jun 23, 2016 · Completed: Mar 31, 2036
11 conditions
3 sponsors
4 locations
NCT02321501
Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
PHASE1
Active, not recruiting
37 participants
Started: Jun 22, 2016 · Completed: Dec 31, 2026
6 conditions
2 sponsors
1 location
NCT02792582
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
PHASE2
Active, not recruiting
160 participants
Started: Jun 22, 2016 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT02718833
A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma
PHASE2
Active, not recruiting
52 participants
Started: Jun 21, 2016 · Completed: Jun 30, 2026
1 condition
4 sponsors
6 locations
NCT02926196
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab
PHASE3
Active, not recruiting
474 participants
Started: Jun 17, 2016 · Completed: Oct 31, 2025
1 condition
3 sponsors
70 locations
NCT02716116
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer
PHASE1/PHASE2
Active, not recruiting
334 participants
Started: Jun 16, 2016 · Completed: Oct 31, 2026
1 condition
1 sponsor
62 locations
NCT02839291
Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
NA
Active, not recruiting
148 participants
Started: Jun 14, 2016 · Completed: Jan 31, 2025
1 condition
1 sponsor
2 locations
NCT02432963
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
PHASE1
Active, not recruiting
11 participants
Started: Jun 14, 2016 · Completed: Oct 31, 2025
17 conditions
2 sponsors
1 location
NCT02775383
The National Myelodysplastic Syndromes (MDS) Study
N/A
Active, not recruiting
3,500 participants
Started: Jun 13, 2016 · Completed: Aug 31, 2025
1 condition
2 sponsors
281 locations
NCT02112565
RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists
PHASE1
Active, not recruiting
12 participants
Started: Jun 13, 2016 · Completed: Jun 1, 2026
1 condition
2 sponsors
1 location
NCT05121636
Clinical Outcomes Following Total Joint Replacement With Corin Prostheses: Corin MetaFix Collared Stem
N/A
Active, not recruiting
51 participants
Started: Jun 12, 2016 · Completed: Sep 2, 2027
1 condition
1 sponsor
0 locations
NCT03675152
Treatment of Spondylolysisin Pediatric Patients.
NA
Active, not recruiting
60 participants
Started: Jun 12, 2016 · Completed: Jan 30, 2024
2 conditions
2 sponsors
2 locations
NCT03069196
Prevalence and Incidence of Complications of Type One Diabetes in PUne At a Tertiary Care CentRE
N/A
Active, not recruiting
323 participants
Started: Jun 10, 2016 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT02581137
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
PHASE2
Active, not recruiting
26 participants
Started: Jun 10, 2016 · Completed: Dec 20, 2025
4 conditions
1 sponsor
4 locations
NCT03469674
PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer
PHASE3
Active, not recruiting
550 participants
Started: Jun 10, 2016 · Completed: Dec 31, 2028
2 conditions
3 sponsors
31 locations
NCT03199365
Tu Salud Si Cuenta Intervention in Increasing Physical Activity and Healthy Eating Among Latino Families
NA
Active, not recruiting
80 participants
Started: Jun 10, 2016 · Completed: Apr 30, 2027
1 condition
3 sponsors
1 location
Previous
1
More pages
376
377
378
379
380
381
382
More pages
431
Next